Literature DB >> 7531948

In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation.

H A Lehr1, F Krombach, S Münzing, R Bodlaj, S I Glaubitt, D Seiffge, C Hübner, U H von Andrian, K Messmer.   

Abstract

Oxidized LDL (oxLDL) has been identified as a potent stimulus of leukocyte adhesion to endothelium, a hallmark of early atherogenesis. A cytofluorometric study was performed to further characterize the mechanisms by which oxLDL stimulates the rapid adhesion of leukocytes to endothelium in vitro and in vivo. Incubation (30 minutes at 37 C) of whole blood (diluted with buffered saline to 1 x 10(6) leukocytes/ml) with oxLDL (0.85 mg LDL cholesterol/ml; oxidized by 7.5 mumol/L Cu2+ for 18 hours) but not native LDL stimulated the upregulation of CD11b/CD18 adhesion receptors on neutrophils (anti-leu-15 binding: 178 +/- 16% of baseline, P < 0.01, means +/- SD of n = 10 experiments) and on monocytes (169 +/- 34% of baseline, P < 0.01). This phenomenon was almost entirely inhibited by n-butanol or the vasoactive drug pentoxifylline (PTX), which also significantly reduced oxLDL-induced leukocyte adhesion to venular and arteriolar endothelium, as assessed by intravital microscopy on the dorsal skinfold chamber in hamsters (venules: 49 +/- 19 versus 120 +/- 34 cells/mm2, P < 0.05; arterioles: 9 +/- 4 versus 52 +/- 7 cells/mm2, P < 0.01) 30 minutes after intravenous injection of oxLDL (4 mg/kg body weight; means +/- SD of n = 7 hamsters per group). Butanol and PTX also significantly reduced the upregulation of CD11b/CD18 by f-methionyl-leucyl-phenylalanine (fMLP) and platelet-activating factor (PAF) but not by phorbol myristate acetate (PMA). Whereas fMLP and PAF stimulate leukocytes via binding to specific cell surface receptors and triggering complex signal transduction pathways, PMA bypasses these pathways and directly activates intracellular protein kinase C. By analogy, we propose that oxLDL upregulates CD11b/CD18 through its previously documented ability to stimulate the generation of second messengers. The effect of n-butanol and PTX on receptor presentation cannot be explained by changes in plasma membrane fluidity, as both agents failed to reverse the decrease in plasma membrane fluidity of neutrophils after stimulation with oxLDL, as assessed by fluorescence anisotropy measurement of the membrane marker diphenylhexatriene. Incubation of isolated neutrophils but not of whole blood with oxLDL resulted in a significant loss of L-selectin from the neutrophil surface (anti-TQ-1 binding: 40 +/- 13% of baseline, P < 0.01). A significant loss of this adhesion receptor on neutrophils and monocytes was also observed after stimulation of isolated neutrophils and whole blood with fMLP, PAF, and PMA.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531948      PMCID: PMC1870782     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  55 in total

Review 1.  Structure and function of the leukocyte adhesion molecules CD11/CD18.

Authors:  M A Arnaout
Journal:  Blood       Date:  1990-03-01       Impact factor: 22.113

2.  Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures.

Authors:  D T Fearon; L A Collins
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

3.  Increased plasma membrane fluidity and decreased receptor availability of nonmuscle cells in myotonic dystrophy.

Authors:  C Hübner; S G Lindner; M Albani; M Ballmann; B Keup; M Schürmann; H Stegner; M Claussen; A Kohlschütter
Journal:  J Neurol Sci       Date:  1989-09       Impact factor: 3.181

4.  Effect of pentoxifylline on developmental changes in neutrophil cell surface mobility and membrane fluidity.

Authors:  J A Newton; E R Ashwood; K D Yang; N H Augustine; H R Hill
Journal:  J Cell Physiol       Date:  1989-09       Impact factor: 6.384

5.  Phospholipase D activation is functionally linked to superoxide generation in the human neutrophil.

Authors:  R W Bonser; N T Thompson; R W Randall; L G Garland
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

6.  Membrane fluidity changes accompanying phagocytosis in normal and in chronic granulomatous disease polymorphonuclear leukocytes.

Authors:  L M Ingraham; L A Boxer; R A Haak; R L Baehner
Journal:  Blood       Date:  1981-10       Impact factor: 22.113

7.  Vertical displacement of membrane proteins mediated by changes in microviscosity.

Authors:  H Borochov; M Shinitzky
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

8.  Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937.

Authors:  J Frostegård; J Nilsson; A Haegerstrand; A Hamsten; H Wigzell; M Gidlund
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

9.  Difference in changes of membrane fluidity of polymorphonuclear leukocytes stimulated with phorbol myristate acetate and formyl-methionyl-leucyl-phenylalanine: role of excited oxygen species.

Authors:  M Masuda; Y Komiyama; T Murakami; K Murata; M Hasui; Y Hirabayashi; Y Kobayashi
Journal:  J Leukoc Biol       Date:  1990-02       Impact factor: 4.962

10.  Immunocomplexes stimulate different signalling events to chemoattractants in the neutrophil and regulate L-selectin and beta 2-integrin expression differently.

Authors:  Y Molad; K A Haines; D C Anderson; J P Buyon; B N Cronstein
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

View more
  11 in total

Review 1.  Diagnostic markers of infection in neonates.

Authors:  P C Ng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-05       Impact factor: 5.747

2.  Primed PMNs in healthy mouse and human circulation are first responders during acute inflammation.

Authors:  Noah Fine; Oriyah Barzilay; Chunxiang Sun; Nimali Wellappuli; Farzeen Tanwir; Jeffrey W Chadwick; Morvarid Oveisi; Nikola Tasevski; David Prescott; Martin Gargan; Dana J Philpott; Yigal Dror; Michael Glogauer
Journal:  Blood Adv       Date:  2019-05-28

Review 3.  Newer approaches to the diagnosis of early onset neonatal sepsis.

Authors:  U K Mishra; S E Jacobs; L W Doyle; S M Garland
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-05       Impact factor: 5.747

Review 4.  Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis.

Authors:  Antonie J H H M van Oostrom; Jeroen van Wijk; Manuel Castro Cabezas
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  Obesity and nutrition in acute respiratory distress syndrome.

Authors:  Renee D Stapleton; Benjamin T Suratt
Journal:  Clin Chest Med       Date:  2014-09-24       Impact factor: 2.878

6.  Effects of acute and chronic low density lipoprotein exposure on neutrophil function.

Authors:  Tatsiana Palvinskaya; Maryellen Antkowiak; Elianne Burg; Christopher C Lenox; Niki Ubags; Angela Cramer; Mercedes Rincón; Anne E Dixon; Michael B Fessler; Matthew E Poynter; Benjamin T Suratt
Journal:  Pulm Pharmacol Ther       Date:  2012-10-17       Impact factor: 3.410

7.  Expression of CD11b and CD18 on polymorphonuclear neutrophils stimulated with interleukin-2.

Authors:  Bahaa K A Abdel-Salam; Hossam Ebaid
Journal:  Cent Eur J Immunol       Date:  2014-06-27       Impact factor: 2.085

Review 8.  A head-to-tail view of L-selectin and its impact on neutrophil behaviour.

Authors:  Aleksandar Ivetic
Journal:  Cell Tissue Res       Date:  2018-01-20       Impact factor: 5.249

Review 9.  Functional alterations of myeloid cell subsets in hyperlipidaemia: relevance for atherosclerosis.

Authors:  Oliver Soehnlein; Maik Drechsler; Mihail Hristov; Christian Weber
Journal:  J Cell Mol Med       Date:  2009-11-09       Impact factor: 5.310

Review 10.  Neonatal sepsis: an old problem with new insights.

Authors:  Birju A Shah; James F Padbury
Journal:  Virulence       Date:  2013-11-01       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.